Showing results (21-30 of 734) with videos related to
Sort By:
Pageof 74
Cancer Treatment Reviews|March 30, 2010
Development and approval of the trifunctional antibody catumaxomab (anti-EpCAM x anti-CD3) as a targeted cancer immunotherapyDiane Seimetz, Horst Lindhofer, Carsten BokemeyerJournal of Oncology|May 22, 2010
Tgf-Beta superfamily receptors-targets for antiangiogenic therapy?Jasmin Otten, Carsten Bokemeyer, Walter FiedlerSeminars in Hematology|July 17, 2007
Use of colony-stimulating factors for chemotherapy-associated neutropenia: review of current guidelinesMichael Heuser, Arnold Ganser, Carsten Bokemeyer, et al.Deutsches Arzteblatt International|June 28, 2023
Testicular TumorsSusanne Krege, Christoph Oing, Carsten BokemeyerCancer Management and Research|December 29, 2010
Evolving role of cetuximab in the treatment of colorectal cancerGunter Schuch, Sebastian Kobold, Carsten BokemeyerJournal of Cancer Research and Clinical Oncology|September 18, 2009
Lenalidomide in patients with cisplatin-refractory and multiply relapsed germ cell tumorsKarin Oechsle, Carsten Bokemeyer, Friedemann HoneckerDrugs & Aging|January 7, 2003
Colorectal cancer in the elderly: is palliative chemotherapy of value?Friedemann Honecker, Claus-Henning Köhne, Carsten BokemeyerMedizinische Klinik (Munich, Germany : 1983)|April 26, 2003
[Elderly patients with acute myeloid leukemia: characteristics in biology, patients, and treatment]Ulrich Wedding, Carsten Bokemeyer, Johannes Gobertus Meran, et al.Deutsche Medizinische Wochenschrift (1946)|January 29, 2024
[Advanced renal cell carcinoma - an overview of current systemic therapy]Moritz Kaune, Carsten Bokemeyer, Gunhild von AmsbergJournal of Cancer Research and Clinical Oncology|July 14, 2005
Accurate measurement of individual glomerular filtration rate in cancer patients: an ongoing challengeKarin Holweger, Carsten Bokemeyer, Hans-Peter LippPageof 74